Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Total Current Liabilities: 2018-2025

Historic Total Current Liabilities for Neurogene (NGNE) over the last 6 years, with Sep 2025 value amounting to $14.7 million.

  • Neurogene's Total Current Liabilities fell 6.90% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year decrease of 6.90%. This contributed to the annual value of $15.2 million for FY2024, which is 34.02% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Total Current Liabilities is $14.7 million, which was down 4.73% from $15.4 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Total Current Liabilities ranged from a high of $23.0 million in Q4 2023 and a low of $4.9 million during Q2 2023.
  • Moreover, its 3-year median value for Total Current Liabilities was $14.1 million (2025), whereas its average is $12.8 million.
  • Data for Neurogene's Total Current Liabilities shows a peak YoY increase of 203.15% (in 2024) and a maximum YoY decrease of 34.02% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Neurogene's Total Current Liabilities stood at $23.0 million in 2023, then tumbled by 34.02% to $15.2 million in 2024, then fell by 6.90% to $14.7 million in 2025.
  • Its Total Current Liabilities was $14.7 million in Q3 2025, compared to $15.4 million in Q2 2025 and $14.1 million in Q1 2025.